197 related articles for article (PubMed ID: 17346248)
1. A comparative pharmacokinetic study in healthy volunteers of the effect of carbamazepine and oxcarbazepine on cyp3a4.
Andreasen AH; Brøsen K; Damkier P
Epilepsia; 2007 Mar; 48(3):490-6. PubMed ID: 17346248
[TBL] [Abstract][Full Text] [Related]
2. Effect of Piperine on the Metabolism and Pharmacokinetics of Carbamazepine in Healthy Volunteers.
Bedada SK; Appani R; Boga PK
Drug Res (Stuttg); 2017 Jan; 67(1):46-51. PubMed ID: 27776366
[TBL] [Abstract][Full Text] [Related]
3. Effect of probenecid on the pharmacokinetics of carbamazepine in healthy subjects.
Kim KA; Oh SO; Park PW; Park JY
Eur J Clin Pharmacol; 2005 Jun; 61(4):275-80. PubMed ID: 15915352
[TBL] [Abstract][Full Text] [Related]
4. Quinidine as a probe for CYP3A4 activity: intrasubject variability and lack of correlation with probe-based assays for CYP1A2, CYP2C9, CYP2C19, and CYP2D6.
Damkier P; Brøsen K
Clin Pharmacol Ther; 2000 Aug; 68(2):199-209. PubMed ID: 10976551
[TBL] [Abstract][Full Text] [Related]
5. Effect of resveratrol on the pharmacokinetics of carbamazepine in healthy human volunteers.
Bedada SK; Nearati P
Phytother Res; 2015 May; 29(5):701-6. PubMed ID: 25624269
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of oxcarbazepine and carbamazepine in human placenta.
Pienimäki P; Lampela E; Hakkola J; Arvela P; Raunio H; Vähäkangas K
Epilepsia; 1997 Mar; 38(3):309-16. PubMed ID: 9070593
[TBL] [Abstract][Full Text] [Related]
7. A single and multiple dose bioavailability study with carbamazepine 400 mg retard tablets with reference to enzyme autoinduction and circadian time differences.
Hoffmann C; Zschiesche M; Franke G; Hoffmann A; Terhaag B; Möritz KU; Siegmund W
Int J Clin Pharmacol Ther; 1997 Nov; 35(11):496-503. PubMed ID: 9401830
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic effects of ciprofloxacin on the pharmacokinetics of carbamazepine in healthy adult male volunteers.
Shahzadi A; Javed I; Aslam B; Muhammad F; Asi MR; Ashraf MY; Zia-ur-Rahman
Pak J Pharm Sci; 2011 Jan; 24(1):63-8. PubMed ID: 21190921
[TBL] [Abstract][Full Text] [Related]
9. A limited sampling method for the estimation of AUC and Cmax of carbamazepine and carbamazepine epoxide following a single and multiple dose of a sustained-release product.
Mahmood I; Chamberlin N
Br J Clin Pharmacol; 1998 Mar; 45(3):241-6. PubMed ID: 9517367
[TBL] [Abstract][Full Text] [Related]
10. Memory and psychomotor effects of oxcarbazepine in healthy human volunteers.
Curran HV; Java R
Eur J Clin Pharmacol; 1993; 44(6):529-33. PubMed ID: 8405007
[TBL] [Abstract][Full Text] [Related]
11. Assessment of the bioequivalence of two oxcarbazepine oral suspensions versus a film-coated tablet in healthy subjects.
Flesch G; Tudor D; Denouel J; Bonner J; Camisasca R
Int J Clin Pharmacol Ther; 2003 Jul; 41(7):299-308. PubMed ID: 12875346
[TBL] [Abstract][Full Text] [Related]
12. Usefulness of salivary drug monitoring for detecting efflux transporter overexpression.
Fagiolino P; Vázquez M; Maldonado C; Ruiz ME; Volonté MG; Orozco-Suárez S; Lazarowski A
Curr Pharm Des; 2013; 19(38):6701-8. PubMed ID: 23530513
[TBL] [Abstract][Full Text] [Related]
13. Parent drug and/or metabolite? Which of them is most appropriate to establish bioequivalence of two oral oxcarbazepine formulations in healthy volunteers?
Di Girolamo G; Opezzo JA; Schere D; Gonzalez CD; Moncalvo JJ
Expert Opin Pharmacother; 2007 Jul; 8(10):1415-23. PubMed ID: 17661724
[TBL] [Abstract][Full Text] [Related]
14. Relative bioavailability, metabolism and tolerability of rectally administered oxcarbazepine suspension.
Clemens PL; Cloyd JC; Kriel RL; Remmel RP
Clin Drug Investig; 2007; 27(4):243-50. PubMed ID: 17358096
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the potential for pharmacokinetic drug-drug interaction between armodafinil and carbamazepine in healthy adults.
Darwish M; Bond M; Yang R; Hellriegel ET; Robertson P
Clin Ther; 2015 Feb; 37(2):325-37. PubMed ID: 25438721
[TBL] [Abstract][Full Text] [Related]
16. Effects of sinapic acid on hepatic cytochrome P450 3A2, 2C11, and intestinal P-glycoprotein on the pharmacokinetics of oral carbamazepine in rats: Potential food/herb-drug interaction.
Raish M; Ahmad A; Ansari MA; Alkharfy KM; Ahad A; Al-Jenoobi FI; Al-Mohizea AM; Khan A; Ali N
Epilepsy Res; 2019 Jul; 153():14-18. PubMed ID: 30927680
[TBL] [Abstract][Full Text] [Related]
17. Oxcarbazepine does not interact with cimetidine in healthy volunteers.
Keränen T; Jolkkonen J; Klosterskov-Jensen P; Menge GP
Acta Neurol Scand; 1992 Apr; 85(4):239-42. PubMed ID: 1585795
[TBL] [Abstract][Full Text] [Related]
18. Influence of diosmin on the metabolism and disposition of carbamazepine in healthy subjects.
Bedada SK; Boga PK
Xenobiotica; 2017 Oct; 47(10):879-884. PubMed ID: 27690733
[TBL] [Abstract][Full Text] [Related]
19. Modulation of CYP3A enzyme activity by diosmin and its consequence on carbamazepine pharmacokinetics in rats.
Bedada SK; Neerati P
Naunyn Schmiedebergs Arch Pharmacol; 2018 Feb; 391(2):115-121. PubMed ID: 29134244
[TBL] [Abstract][Full Text] [Related]
20. Serum carbamazepine concentrations in elderly patients: a case-matched pharmacokinetic evaluation based on therapeutic drug monitoring data.
Battino D; Croci D; Rossini A; Messina S; Mamoli D; Perucca E
Epilepsia; 2003 Jul; 44(7):923-9. PubMed ID: 12823575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
